High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumors - Top-Institutions - MDSpire

High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumors

  • By

  • Junichi Hara

  • Kimikazu Matsumoto

  • Naoko Maeda

  • Mariko Takahara-Matsubara

  • Saori Sugimoto

  • Hiroaki Goto

  • November 3, 2022

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Oncology
    • Hematopoietic Stem Cell Transplantation
    • Neuro-oncology

  • #2

    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    Boston, MA

    Key Differentiators

    • Pediatric Oncology
    • Stem Cell Transplantation
    • Neuro-oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Pediatric Oncology
    • Hematopoietic Stem Cell Transplantation
    • Neuro-oncology

  • #4

    Tokyo Metropolitan Children's Medical Center
    Tokyo Metropolitan Children's Medical Center

    Tokyo, Tokyo Prefecture

    Key Differentiators

    • Pediatric Oncology
    • Hematopoietic Stem Cell Transplantation

  • #5

    Great Ormond Street Hospital for Children
    Great Ormond Street Hospital for Children

    London, England

    Key Differentiators

    • Pediatric Oncology
    • Stem Cell Transplantation
    • Neuro-oncology

Original Source(s)

High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumors

  • by Junichi Hara, Kimikazu Matsumoto, Naoko Maeda, Mariko Takahara-Matsubara, Saori Sugimoto, Hiroaki Goto

  • November 3, 2022

Related Content

A prospective study of shared decision-making in brain tumor surgery

Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study

Clinical and imaging manifestations of intracerebral hemorrhage in brain tumors and metastatic lesions: a comprehensive overview